NIH #U01CA294124
Desmoplastic small round cell tumor: harnessing new insights and new models
Active
- Amount
- $500K–$600K
- Period
- 2024-09-01 → 2029-08-31
- PIs
- 2
Awarded at SLOAN-KETTERING INST CAN RESEARCH
Marc Ladanyi
Full Professor(heuristic)
Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine
Compare more Pulmonary and Respiratory Medicine professors.
h-index207
i10-index681
Publications2,492
Citations211,769
Grants
5 total · 2 active
NIH #P50CA217694
Project 3: Identifying Targetable Epigenetic and Immuno-Oncologic Vulnerabilities in Synovial Sarcoma
Active
- Amount
- $400K–$500K
- Period
- 2018-09-01 → 2029-08-31
- PIs
- 1
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #P50CA140146
P4 Elucidating SYT-SSX-depend histone code alterations to guide targeted epigenet
- Amount
- $200K–$300K
- Period
- — → 2018-06-30
- PIs
- 1
Awarded at SLOAN-KETTERING INST CAN RESEARCH
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: 1649 Epithelioid Histology, Tubulopapillary Architecture, and Low Nuclear Grade Are Associated With Long-Term Survival in Diffuse Pleural Mesothelioma (Laboratory Investigation)2026-03-01
- New NIH award: Desmoplastic small round cell tumor: harnessing new insights and new models2024-09-01
- New NIH award: Project 3: Identifying Targetable Epigenetic and Immuno-Oncologic Vulnerabilities in Synovial Sarcoma2018-09-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-03
Data may not be current
Find elsewhere
ORCID: 0000-0001-9055-7213